Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 4 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2020 Filed Mar 18, 2020 23:27 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.58 | $2,370.00 |
DisclosureSEC source: 0001209191-20-020105 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,488,243 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.62, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 13, 2020 Filed Mar 13, 2020 22:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,100 | $1.61 | $9,821.00 |
DisclosureSEC source: 0001209191-20-019028 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,486,743 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.75, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 12, 2020 Filed Mar 13, 2020 22:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,000 | $1.55 | $4,650.00 |
DisclosureSEC source: 0001209191-20-019028 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480,643 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.51 to $1.63, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 11, 2020 Filed Mar 12, 2020 20:09 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,200 | $1.64 | $1,968.00 |
DisclosureSEC source: 0001209191-20-018467 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By FMT CO CUST IRA FBO Willis Lee Disclosed balance after: 13,650 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.64, inclusive. Read SEC document |
| March 11, 2020 Filed Mar 13, 2020 22:37 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001209191-20-019028 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,477,643 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.70, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 10, 2020 Filed Mar 10, 2020 21:05 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,750 | $1.82 | $6,825.00 |
DisclosureSEC source: 0001209191-20-017750 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,475,143 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.90, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:09 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,300 | $1.72 | $2,236.00 |
DisclosureSEC source: 0001209191-20-018467 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By FMT CO CUST IRA FBO Willis Lee Disclosed balance after: 12,450 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.68 to $1.81, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| March 09, 2020 Filed Mar 9, 2020 23:10 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 9,500 | $1.32 | $12,540.00 |
DisclosureSEC source: 0001209191-20-017496 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By FMT CO CUST IRA FBO Willis Lee Disclosed balance after: 11,150 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.44, inclusive. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 21:05 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 11,600 | $1.31 | $15,196.00 |
DisclosureSEC source: 0001209191-20-017750 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,471,393 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.45, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 06, 2020 Filed Mar 10, 2020 21:05 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 27,500 | $1.45 | $39,875.00 |
DisclosureSEC source: 0001209191-20-017750 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,459,793 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.51, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 05, 2020 Filed Mar 6, 2020 00:10 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 10,150 | $1.70 | $17,255.00 |
DisclosureSEC source: 0001209191-20-016772 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,432,293 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.60 to $1.70, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 23:10 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,650 | $1.68 | $2,772.00 |
DisclosureSEC source: 0001209191-20-017496 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By FMT CO CUST IRA FBO Willis Lee Disclosed balance after: 1,650 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.60 to $1.70, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 00:10 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,850 | $1.64 | $7,954.00 |
DisclosureSEC source: 0001209191-20-016772 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,422,143 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.70, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:10 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 8,750 | $1.66 | $14,525.00 |
DisclosureSEC source: 0001209191-20-016772 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,417,293 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.80, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 21, 2020 Filed Feb 22, 2020 00:51 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 24,500 | $1.84 | $45,080.00 |
DisclosureSEC source: 0001209191-20-011812 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,408,543 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.68 to $1.91, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 00:51 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 15,500 | $1.80 | $27,900.00 |
DisclosureSEC source: 0001209191-20-011812 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,384,043 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.91, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 00:51 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 8,000 | $1.70 | $13,600.00 |
DisclosureSEC source: 0001209191-20-011812 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,368,543 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.72, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 18, 2020 Filed Feb 18, 2020 23:10 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,000 | $1.72 | $6,880.00 |
DisclosureSEC source: 0001209191-20-010336 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,360,543 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.70 to $1.72, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 23:10 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 13,700 | $1.85 | $25,345.00 |
DisclosureSEC source: 0001209191-20-010336 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,356,543 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.77 to $1.87, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 18:33 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,100 | $1.80 | $1,980.00 |
DisclosureSEC source: 0001209191-20-009517 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,624 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $1.80, inclusive. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 23:10 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,050 | $1.80 | $9,090.00 |
DisclosureSEC source: 0001209191-20-010336 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,342,843 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $1.91, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 12, 2020 Filed Feb 12, 2020 23:49 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,400 | $1.86 | $8,184.00 |
DisclosureSEC source: 0001209191-20-008987 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,337,793 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $1.90, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 18:33 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,900 | $1.75 | $3,325.00 |
DisclosureSEC source: 0001209191-20-009517 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,524 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.70 to $1.76, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 23:49 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 17,500 | $1.84 | $32,200.00 |
DisclosureSEC source: 0001209191-20-008987 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,333,393 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.77 to $1.89, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 23:49 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 9,200 | $1.71 | $15,732.00 |
DisclosureSEC source: 0001209191-20-008987 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,315,893 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.70 to $1.73, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1), in footnote (3) and in footnote (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 17:29 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,000 | $1.46 | $7,300.00 |
DisclosureSEC source: 0001209191-20-007817 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,306,693 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.64, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 17:25 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 2,600 | $1.43 | $3,718.00 |
DisclosureSEC source: 0001209191-20-007815 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,624 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.35 to $1.49, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2). Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 17:29 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 13,800 | $1.21 | $16,698.00 |
DisclosureSEC source: 0001209191-20-007817 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,301,693 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.13 to $1.27, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 17:25 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,950 | $1.15 | $2,242.50 |
DisclosureSEC source: 0001209191-20-007815 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,024 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.12 to $1.17, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| November 01, 2019 Filed Nov 1, 2019 22:19 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 800 | $2.98 | $2,384.00 |
DisclosureSEC source: 0001209191-19-054769 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,074 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.89 to $2.99, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 21:15 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 16,500 | $2.98 | $49,170.00 |
DisclosureSEC source: 0001209191-19-054880 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,287,893 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.86 to $3.10, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 22:19 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 1,000 | $2.90 | $2,900.00 |
DisclosureSEC source: 0001209191-19-054769 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,274 Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 18:31 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $2.91 | $5,820.00 |
DisclosureSEC source: 0001209191-19-054693 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,271,393 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.90 to $2.95, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 18:31 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,500 | $2.57 | $8,995.00 |
DisclosureSEC source: 0001209191-19-054693 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,269,393 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.33 to $2.88, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 18, 2019 Filed Oct 18, 2019 20:03 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 3,890 | $2.79 | $10,853.10 |
DisclosureSEC source: 0001209191-19-053596 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,274 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.80, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| October 18, 2019 Filed Oct 21, 2019 18:03 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 7,000 | $2.78 | $19,460.00 |
DisclosureSEC source: 0001209191-19-053674 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,265,893 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.80, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:03 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 4,000 | $2.51 | $10,040.00 |
DisclosureSEC source: 0001209191-19-053596 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,384 Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 16:44 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,500 | $2.72 | $17,680.00 |
DisclosureSEC source: 0001209191-19-053570 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,258,893 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.45 to $2.79, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 18:48 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 10,300 | $2.70 | $27,810.00 |
DisclosureSEC source: 0001209191-19-053259 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,252,393 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.40 to $2.76, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 18:41 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 7,000 | $2.69 | $18,830.00 |
DisclosureSEC source: 0001209191-19-053257 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,384 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.32 to $2.76, inclusive. Read SEC document |
| October 14, 2019 Filed Oct 16, 2019 18:48 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 8,800 | $2.45 | $21,560.00 |
DisclosureSEC source: 0001209191-19-053259 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,242,093 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.26 to $2.74, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| October 14, 2019 Filed Oct 16, 2019 18:41 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 4,000 | $2.47 | $9,880.00 |
DisclosureSEC source: 0001209191-19-053257 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,384 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 18:51 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,000 | $2.29 | $11,450.00 |
DisclosureSEC source: 0001209191-19-050858 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,233,293 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.42, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 24, 2019 Filed Sep 26, 2019 18:51 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,000 | $1.97 | $9,850.00 |
DisclosureSEC source: 0001209191-19-050858 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,228,293 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.82 to $2.10, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1) and (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| September 09, 2019 Filed Sep 10, 2019 21:25 UTC |
ZEN Wei PeuDirector
|
PurchaseCommon stock, $0.001 par value | 20,000 | $4.30 | $86,000.00 |
DisclosureSEC source: 0001209191-19-049051 · doc4.xml · nonDerivative · entry 2 ZEN Wei Peu · CIK 0001746204 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Smart Start Investments Limited Disclosed balance after: 375,308 Read SEC document |
| September 09, 2019 Filed Sep 10, 2019 21:25 UTC |
ZEN Wei PeuDirector
|
PurchaseCommon stock, $0.001 par value | 20,000 | $4.20 | $84,000.00 |
DisclosureSEC source: 0001209191-19-049051 · doc4.xml · nonDerivative · entry 1 ZEN Wei Peu · CIK 0001746204 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Smart Start Investments Limited Disclosed balance after: 355,308 F1 · ownership.nature: Smart Start Investments Limited is a Hong Kong limited company and wholly owned subsidiary of Build King Holdings Limited, a Hong Kong stock exchange listed company of which the Reporting Person is a director and 9.93% shareholder. The Reporting Person also is a director of Smart Start Investments Limited. The Reporting Person disclaims beneficial ownership of the shares shown except to the extent of his pecuniary interest therein. The inclusion in this Report of such shares shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 21:02 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,827 | $4.26 | $12,043.02 |
DisclosureSEC source: 0001209191-19-048789 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Soomi Niihara Disclosed balance after: 63,000 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.23 to $4.31, inclusive. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 18:52 UTC |
ZEN Wei PeuDirector
|
PurchaseCommon stock, $0.001 par value | 12,545 | $4.20 | $52,689.00 |
DisclosureSEC source: 0001209191-19-048866 · doc4.xml · nonDerivative · entry 1 ZEN Wei Peu · CIK 0001746204 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Smart Start Investments Limited Disclosed balance after: 335,308 F1 · ownership.nature: Smart Start Investments Limited is a Hong Kong limited company and wholly owned subsidiary of Build King Holdings Limited, a Hong Kong stock exchange listed company of which the Reporting Person is a director and 9.93% shareholder. The Reporting Person also is a director of Smart Start Investments Limited. The Reporting Person disclaims beneficial ownership of the shares shown except to the extent of his pecuniary interest therein. The inclusion in this Report of such shares shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 21:02 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 9,672 | $4.04 | $39,074.88 |
DisclosureSEC source: 0001209191-19-048789 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Soomi Niihara Disclosed balance after: 60,173 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.92 to $4.10, inclusive. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 19:29 UTC |
ZEN Wei PeuDirector
|
PurchaseCommon stock, $0.001 par value | 20,000 | $4.00 | $80,000.00 |
DisclosureSEC source: 0001209191-19-048706 · doc4.xml · nonDerivative · entry 3 ZEN Wei Peu · CIK 0001746204 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Smart Start Investments Limited Disclosed balance after: 322,763 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.